Comments on the NMDA antagonist memantine
Gespeichert in:
| Veröffentlicht in: | Methods and Findings in Experimental and Clinical Pharmacology 2003-04, Vol.25 (3), p.173-173 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 173 |
|---|---|
| container_issue | 3 |
| container_start_page | 173 |
| container_title | Methods and Findings in Experimental and Clinical Pharmacology |
| container_volume | 25 |
| creator | FISCHHOF, P. K |
| description | |
| doi_str_mv | 10.1358/mf.2003.25.3.769758 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73301976</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73301976</sourcerecordid><originalsourceid>FETCH-LOGICAL-c281t-d4b5192b2a44082ce4ef5d6de90f64c5402f92c9d2c314d390bc24783a34493b3</originalsourceid><addsrcrecordid>eNpFkE1LxDAURbNQnHH0FwjSjYKL1iQvaZrlMOMXjLrRdUjTRCtNOjbtwn9vhxZm9bhw7uVxELoiOCPAi3vvMooxZJRnkIlcCl6coCUGIVMMnC_QeYw_GFPCgZ-hBaGCQU7kEt1tWu9t6GPShqT_tsnb63ad6NDrrzbUsU-89WOqg71Ap0430V7Od4U-Hx8-Ns_p7v3pZbPepYYWpE8rVnIiaUk1Y7igxjLreJVXVmKXM8MZpk5SIytqgLAKJC4NZaIADYxJKGGFbqfdfdf-Djb2ytfR2KbRwbZDVAIAEynyEYQJNF0bY2ed2ne1192fIlgdrCjv1MGKolyBmqyMret5fii9rY6dWckI3MyAjkY3rtPB1PHIjb8yzjj8A9sVaro</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73301976</pqid></control><display><type>article</type><title>Comments on the NMDA antagonist memantine</title><source>Portico Triggered Ejournal For Participants</source><source>MEDLINE</source><creator>FISCHHOF, P. K</creator><creatorcontrib>FISCHHOF, P. K</creatorcontrib><identifier>ISSN: 0379-0355</identifier><identifier>ISSN: 2013-0155</identifier><identifier>DOI: 10.1358/mf.2003.25.3.769758</identifier><identifier>PMID: 12743619</identifier><language>eng</language><publisher>Barcelona: Prous</publisher><subject>Aged ; Biological and medical sciences ; Clinical Trials as Topic ; Dementia - drug therapy ; Dopamine Agents - therapeutic use ; Humans ; Medical sciences ; Memantine - therapeutic use ; N-Methylaspartate - antagonists & inhibitors ; Neuropharmacology ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology</subject><ispartof>Methods and Findings in Experimental and Clinical Pharmacology, 2003-04, Vol.25 (3), p.173-173</ispartof><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14784545$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12743619$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FISCHHOF, P. K</creatorcontrib><title>Comments on the NMDA antagonist memantine</title><title>Methods and Findings in Experimental and Clinical Pharmacology</title><addtitle>Methods Find Exp Clin Pharmacol</addtitle><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Clinical Trials as Topic</subject><subject>Dementia - drug therapy</subject><subject>Dopamine Agents - therapeutic use</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Memantine - therapeutic use</subject><subject>N-Methylaspartate - antagonists & inhibitors</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><issn>0379-0355</issn><issn>2013-0155</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1LxDAURbNQnHH0FwjSjYKL1iQvaZrlMOMXjLrRdUjTRCtNOjbtwn9vhxZm9bhw7uVxELoiOCPAi3vvMooxZJRnkIlcCl6coCUGIVMMnC_QeYw_GFPCgZ-hBaGCQU7kEt1tWu9t6GPShqT_tsnb63ad6NDrrzbUsU-89WOqg71Ap0430V7Od4U-Hx8-Ns_p7v3pZbPepYYWpE8rVnIiaUk1Y7igxjLreJVXVmKXM8MZpk5SIytqgLAKJC4NZaIADYxJKGGFbqfdfdf-Djb2ytfR2KbRwbZDVAIAEynyEYQJNF0bY2ed2ne1192fIlgdrCjv1MGKolyBmqyMret5fii9rY6dWckI3MyAjkY3rtPB1PHIjb8yzjj8A9sVaro</recordid><startdate>20030401</startdate><enddate>20030401</enddate><creator>FISCHHOF, P. K</creator><general>Prous</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030401</creationdate><title>Comments on the NMDA antagonist memantine</title><author>FISCHHOF, P. K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c281t-d4b5192b2a44082ce4ef5d6de90f64c5402f92c9d2c314d390bc24783a34493b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Clinical Trials as Topic</topic><topic>Dementia - drug therapy</topic><topic>Dopamine Agents - therapeutic use</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Memantine - therapeutic use</topic><topic>N-Methylaspartate - antagonists & inhibitors</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FISCHHOF, P. K</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Methods and Findings in Experimental and Clinical Pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FISCHHOF, P. K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comments on the NMDA antagonist memantine</atitle><jtitle>Methods and Findings in Experimental and Clinical Pharmacology</jtitle><addtitle>Methods Find Exp Clin Pharmacol</addtitle><date>2003-04-01</date><risdate>2003</risdate><volume>25</volume><issue>3</issue><spage>173</spage><epage>173</epage><pages>173-173</pages><issn>0379-0355</issn><issn>2013-0155</issn><cop>Barcelona</cop><pub>Prous</pub><pmid>12743619</pmid><doi>10.1358/mf.2003.25.3.769758</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0379-0355 |
| ispartof | Methods and Findings in Experimental and Clinical Pharmacology, 2003-04, Vol.25 (3), p.173-173 |
| issn | 0379-0355 2013-0155 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73301976 |
| source | Portico Triggered Ejournal For Participants; MEDLINE |
| subjects | Aged Biological and medical sciences Clinical Trials as Topic Dementia - drug therapy Dopamine Agents - therapeutic use Humans Medical sciences Memantine - therapeutic use N-Methylaspartate - antagonists & inhibitors Neuropharmacology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology |
| title | Comments on the NMDA antagonist memantine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T19%3A05%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comments%20on%20the%20NMDA%20antagonist%20memantine&rft.jtitle=Methods%20and%20Findings%20in%20Experimental%20and%20Clinical%20Pharmacology&rft.au=FISCHHOF,%20P.%20K&rft.date=2003-04-01&rft.volume=25&rft.issue=3&rft.spage=173&rft.epage=173&rft.pages=173-173&rft.issn=0379-0355&rft_id=info:doi/10.1358/mf.2003.25.3.769758&rft_dat=%3Cproquest_cross%3E73301976%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73301976&rft_id=info:pmid/12743619&rfr_iscdi=true |